boy taking medicine

Children’s Advil Recalled for Overdose Concerns

Pfizer is recalling some children’s Advil due to a discrepancy between the instructions on the label and the product’s measuring cup. Many are concerned that the mislabeling could cause a potential overdose.

Children’s Advil Recall

Type: Children’s Advil Suspension bubble-gum flavored 4 fl. oz.

Expiration date: November 2020

Lot: #R51129

UPC #: 3-0573-0207-30-0

The Problem

Customers complained that the dosage cup is marked in teaspoons while the instructions refer to milliliters. One teaspoon is equivalent to approximately five milliliters.

“Pfizer concluded that the use of the product with an unmatched dosage cup marked in teaspoons rather than milliliters has a chance of being associated with potential overdose,” the company said in its announcement.

The active ingredient in Advil is ibuprofen. Symptoms of an ibuprofen overdose include nausea, vomiting, drowsiness, blurred vision, and dizziness.

Contact GoldenbergLaw

If your child took recalled children’s Advil and experienced symptoms of ibuprofen overdose, contact the dangerous drug attorneys at GoldenbergLaw. We have successfully handled defective products cases for children. Leave the sleepless nights to us.

Categories

We Truly Care

The GoldenbergLaw Difference
  • Kindness Is Strength.

    With us, you matter most. This team spends the time to ensure clients like you get to rest and leave the sleepless nights to us.

  • Accountability Is Bravery.

    We live and breathe what we do, and we don't stop until the responsible party is held liable.

  • Leadership Is Trust.

    Our firm has been trusted to lead roles within some of the nation's largest litigations.

  • Knowledge Is Power.

    Our firm is focused on the science of the case and applying it to helping our clients recover.

Contact Us

We Focus On What You Need
  • Please enter your first name.
  • Please enter your last name.
  • Please enter your phone number.
    This isn't a valid phone number.
  • Please enter your email address.
    This isn't a valid email address.
  • Please make a selection.
  • Please enter a message.